Medical specialists from Korea, Republic of tagged as investigators in clinical trials studying Lymphoma, Large B-Cell, Diffuse
Total 37 results
-
Byoung Kook KimSeen in:
- Seoul, Seoul National University Hospital, Seoul National University College of Medicine
Trials:- NCT01178658 (Sub-Investigator)
- NCT01178645 (Sub-Investigator)
Conditions: -
Byung Il Kim, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01678404 (Sub-Investigator)
- NCT01678417 (Sub-Investigator)
- NCT01676558 (Sub-Investigator)
-
Chang Woon Choi, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01678417 (Sub-Investigator)
- NCT01676558 (Sub-Investigator)
-
Dong-Yeop Shin, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01678404 (Sub-Investigator)
- NCT01678417 (Sub-Investigator)
- NCT01676558 (Sub-Investigator)
-
Dongyeop Shin, MD, PhDSeen in:
- Seoul, Seoul National University Hospital
Trials:- NCT05335018 (Sub-Investigator)
-
Hawk Kim, M.D. Ph. D.Seen in:
- Ulsan, Ulsan University Hospital
Trials:- NCT01063439 (Principal Investigator)
Conditions: -
Hong In Yoon, MD PhDSeen in:
- Seoul, Yonsei University Health System
Trials:- NCT03681535 (Principal Investigator)
Conditions: -
Hye Jin Kang, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01678404 (Principal Investigator)
- NCT01676558 (Principal Investigator)
-
HyeonSeok Eom, MDSeen in:
- Other, Goyang-si, National Cancer Center
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Hyo-Rak Lee, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01678404 (Sub-Investigator)
- NCT01678417 (Sub-Investigator)
- NCT01676558 (Sub-Investigator)
-
Hyungwoo ChoSeen in:
- Other, Seoul, Asan Medical Center - Oncology
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Ilhan Im, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01676558 (Sub-Investigator)
-
Im Il Na, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01678404 (Sub-Investigator)
- NCT01678417 (Sub-Investigator)
- NCT01676558 (Sub-Investigator)
-
Inho KimSeen in:
- Seoul, Seoul National University Hospital, Seoul National University College of Medicine
Trials:- NCT01178658 (Sub-Investigator)
- NCT01178645 (Sub-Investigator)
Conditions: -
Jae-Hoon KimSeen in:
- Seoul, Gangnam Severance Hospital
- Seoul, Gangnam Severance Hospital, Yonsei University Health System
Trials:- NCT04251052 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT04095364 (Principal Investigator)
Conditions:- Ovarian Carcinoma;
- Ovarian Cancer;
- Fallopian Tube Cancer;
- Peritoneal Cancer;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Jae-Yong KwakSeen in:
- Jeollabuk-do, Jeonju, Chonbuk National University Hospital
- Jeonju, Jeonbuk National University Hospital
- Other, Jeonju-Si, Jeonbuk National University Hospital
Trials:- NCT03589326 (Principal Investigator)
- NCT04603495 (Principal Investigator)
- NCT04404283 (Principal Investigator)
-
Je Hwan LeeSeen in:
- Seoul, Asan Medical Center, University of Ulsan
- Seoul, Asan Medical Center, University of Ulsan College of Medicine
Trials:- NCT01178658 (Principal Investigator)
- NCT01178645 (Principal Investigator)
- NCT01063439 (Principal Investigator)
Conditions: -
Jeong A Kim, MDSeen in:
- Other, Suwon-si, St. Vincent's Hospital, The Catholic University of Korea
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Jeong-A Kim, MD, Ph.DSeen in:
- Gyeonggi-do, Suwon-si, The Catholic University of Korea, St.Vincent's Hospital
Trials:- NCT02885623 (Principal Investigator)
Conditions: -
Jin Seok Kim, M.D. Ph.D.Seen in:
- Other, Seoul, Severance Hospital, Yonsei University Health System
- Seoul, Yeonsei University Hospital
Trials:- NCT01063439 (Principal Investigator)
- NCT04404283 (Principal Investigator)
Conditions: -
Jin-Hee Jinny ParkSeen in:
- Other, Incheon, Gachon University Gil Medical Center
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Jong-Ho Won, MDSeen in:
- Other, Seoul, Soon Chun Hyang University Hospital Seoul
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Sang Moo Lim, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01678404 (Sub-Investigator)
- NCT01678417 (Sub-Investigator)
- NCT01676558 (Sub-Investigator)
-
Seok-Goo ChoSeen in:
- Other, Seoul, Seoul Saint Mary's Hospital
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Seonyang ParkSeen in:
- Seoul, Seoul National University Hospital, Seoul National University College of Medicine
Trials:- NCT01178658 (Sub-Investigator)
- NCT01178645 (Sub-Investigator)
Conditions: -
Seung Sook Lee, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01676558 (Sub-Investigator)
-
Sung Hyun Yang, M.D.Seen in:
- Seoul, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences
Trials:- NCT01678404 (Sub-Investigator)
- NCT01678417 (Sub-Investigator)
- NCT01676558 (Sub-Investigator)
-
Sung Soo Yoon, M.D. Ph.D.Seen in:
- Seoul, Seoul National University Hospital
Trials:- NCT01063439 (Principal Investigator)
Conditions:
Clinical Trials on Lymphoma, Large B-Cell, Diffuse
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma | Large-cell Lymphoma | Mediastinal B-Cell Diffuse Large Cell LymphomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); AmgenActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 Positive | Stage I Diffuse Large B-Cell Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell LymphomaUnited States
-
University Hospital Southampton NHS Foundation...Hoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited Kingdom
-
National Cancer Institute (NCI)WithdrawnDiffuse, Large B-cell Lymphoma | Lymphoma, Diffuse Large-Cell | Lymphoma, Diffuse Large-Cell B-cell | Large-Cell Lymphoma, Diffuse
-
Qian WenbinNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaChina
-
Dana-Farber Cancer InstituteBayer; AbbVieActive, not recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterSanofi; Columbia University; Medical College of Wisconsin; University of Rochester and other collaboratorsActive, not recruitingDiffuse Large B-cell Lymphoma (DLBCL) | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)United States
-
Autolus LimitedCompletedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | DLBCL | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom
-
Herlev HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Cell of Origin
-
UNC Lineberger Comprehensive Cancer CenterCephalonCompletedLymphoma | Diffuse Large B-Cell Lymphoma | Lymphoma, Diffuse Large-Cell | Diffuse Large-Cell LymphomaUnited States